文献速递生殖医学

因医学指征行卵母细胞或胚胎冷冻保存患者的经历与意向:一项定性研究

Experiences and intentions of patients undergoing medically indicated oocyte or embryo cryopreservation: a qualitative study.
PubMed 文献 · Hum Reprod · 2024-01-01

该定性访谈研究纳入42名因医学指征在学术生育中心行卵母细胞或胚胎冷冻保存的顺性别女性,访谈于2021年3月至2022年3月通过互联网进行。多数女性表示希望使用冷冻材料,但受持续医学问题、需代孕者或缺伴侣等因素阻碍;冷冻保存经历被多数描述为情感上极具挑战。

要点

  • 42名因医学指征冷冻卵母细胞或胚胎的女性中,多数希望使用冷冻材料但尚未使用。
  • 使用冷冻材料的常见障碍包括持续医学问题妨碍妊娠、需代孕者、缺伴侣及希望自然受孕。
  • 多数受访者认为冷冻保存经历情感上极具挑战,癌症患者感到短期决策复杂且压力大。

核心结论

  • 多数因医学指征行卵母细胞或胚胎冷冻保存的女性报告希望使用其冷冻材料,但受到持续医学问题、需代孕者或缺伴侣的阻碍。

研究设计与样本

  • 定性访谈研究,纳入42名于2012年1月至2021年12月期间因医学指征在学术生育中心行卵母细胞或胚胎冷冻保存的顺性别女性,访谈于2021年3月至2022年3月通过互联网进行,采用主题分析及持续比较法分析数据。

主要发现

  • 42名女性访谈时中位年龄35岁(范围28-43),冷冻保存时中位年龄31岁(范围25-39)。
  • 42名女性中30例为癌症诊断,7例为非癌症慢性疾病,5例为遗传性癌症易感综合征;12例冻存胚胎,30例冻存卵母细胞。
  • 4例已使用冷冻卵母细胞或胚胎,另4例未经辅助生殖即妊娠。
  • 多数女性表示希望使用冷冻材料,但许多人不确定如何使用或何时使用。
  • 报告的常见使用障碍包括持续医学问题妨碍妊娠、需代孕者、缺伴侣及希望自然受孕。

临床怎么用

  • 了解因医学指征行卵母细胞和胚胎冷冻保存患者的经历,可帮助临床医生更好地就患者可能面临的决定和障碍进行咨询。
  • 作者发现多数患者尚未返回使用冷冻材料,原因包括持续医学问题、需代孕者、缺伴侣或希望尝试自然受孕。

局限性

  • 多数参与者的卵母细胞或胚胎在单一城市学术生育中心冷冻,可能限制普适性。
  • 因采用滚雪球技术识别额外参与者,无法计算应答率,故不知道受邀参与的总人数。
  • 与其他访谈研究一样,本研究可能存在应答偏倚,因为同意参与者可能对其经历持有特别正面或负面的看法。
  • 此外,自冷冻以来的平均随访时间相对较短(3.3年,中位2.7年),对某些患者而言可能不足以使用其冷冻材料。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: What structural (logistical) and psychological challenges do patients who cryopreserve oocytes or embryos for medical reasons face, including possible barriers to using their frozen materials? SUMMARY ANSWER: The majority of women who underwent oocyte or embryo cryopreservation for medical reasons reported a desire to use their frozen oocytes or embryos but had been impeded by ongoing medical issues, the need for a gestational carrier, or the lack of a partner. WHAT IS KNOWN ALREADY: Current data suggest that many women who have frozen oocytes or embryos for medical indications are concerned about the prospect of infertility and have unique emotional and financial needs that differ from patients with infertility. Further, most patients have not returned to use their cryopreserved materials. STUDY DESIGN, SIZE, DURATION: This is a qualitative interview study of 42 people who cryopreserved between January 2012 and December 2021. Interviews were conducted between March 2021 and March 2022. PARTICIPANTS/MATERIALS, SETTING, METHODS: All participants were cisgender women who had undergone oocyte or embryo cryopreservation for medical indications at an academic fertility center. Participants were invited to interview by email if they were younger than 40 years old when their oocytes or embryos were cryopreserved. Interviews were conducted over the internet and transcribed verbatim. Data were analyzed using thematic analysis with the constant comparison method. MAIN RESULTS AND THE ROLE OF CHANCE: Saturation was reached at 42 interviews. The median age of participants was 35 years old (range 28-43) at interview and 31 years old (range 25-39) at cryopreservation. Of the 42 women, 30 had a cancer diagnosis, while 7 had non-cancer chronic medical conditions, and 5 had hereditary cancer susceptibility syndromes. There were 12 women who banked embryos and 30 who banked oocytes. The majority of women indicated a desire to use their cryopreserved materials, but many were unsure about how or when. Four had already used their frozen oocytes or embryos, while another four had conceived without assisted reproduction. The cryopreservation experience was described by the majority as highly emotionally challenging because they felt out of place among couples receiving infertility treatment and, for cancer patients, overwhelmed by the complex decisions to be made in a short time period. Common reported barriers to using frozen materials included ongoing medical issues preventing pregnancy, the need for a gestational carrier, the lack of a partner, and the desire for unassisted conception. Some were glad to have frozen oocytes or embryos to allow more time to meet a partner or if they were considering becoming single parents. LIMITATIONS, REASONS FOR CAUTION: The majority of participants had their oocytes or embryos frozen at a single, urban, academic fertility center, which may limit generalizability. We also could not calculate a response rate because the snowball technique was used to identify additional participants, so did not know the total number of people invited to participate. Like other interview studies, our study may be subject to response bias because those who agreed to participate may have particularly positive or negative views about their experiences. Furthermore, the mean follow-up time since freezing was relatively short (3.3 years, median 2.7 years), which may not have been enough time for some patients to use their frozen materials. WIDER IMPLICATIONS OF THE FINDINGS: Learning about the experiences of patients undergoing medically indicated oocyte and embryo cryopreservation can help clinicians better counsel these patients regarding decisions and hurdles they may encounter. We found that most patients had not returned to use their frozen materials because of ongoing medical issues, the need for a gestational carrier, lack of a partner, or the desire to attempt unassisted reproduction. STUDY FUNDING/COMPETING INTEREST(S): This study did not receive any funding. The authors of this study have no conflicts of interest to declare. TRIAL REGISTRATION NUMBER: N/A.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Bayefsky MJ, Sampson A, Blakemore JK, et al. Experiences and intentions of patients undergoing medically indicated oocyte or embryo cryopreservation: a qualitative study. Hum Reprod. 2024. PMID: 37944107. doi:10.1093/humrep/dead228

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。